Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
133 participants
INTERVENTIONAL
2020-11-30
2022-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Steri Strips Arm
Steri Strips
Steri Strips will be applied after subcuticular skin closure as routinely done at our institution
Dermabond Arm
Dermabond
Dermabond will be applied after subcuticular skin closure in lieu of Steri Strips
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dermabond
Dermabond will be applied after subcuticular skin closure in lieu of Steri Strips
Steri Strips
Steri Strips will be applied after subcuticular skin closure as routinely done at our institution
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational age \> 24 weeks
* Planned Pfannenstiel incision
* Willing to consent to the study
Exclusion Criteria
* Vertical skin incision
* Intrapartum intraamniotic infection
* Diabetes
* Unwilling to consent to the study
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Tennessee
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Laura Grese Willingham
Assistant Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-07302-FB
Identifier Type: -
Identifier Source: org_study_id